NCT07620223 Prophylactic Antibiotics in Preventing Surgical Site Infection After Hepatobiliary Surgery in High-Resistant Settings
| NCT ID | NCT07620223 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
| Condition | Hepatobiliary Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 378 participants |
| Start Date | 2026-05-24 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 378 participants in total. It began in 2026-05-24 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To analyse the efficacy of different preoperative prophylactic antimicrobial regimens for perioperative infection prevention in patients undergoing hepatobiliary surgery in a high antimicrobial resistance setting.
Eligibility Criteria
Inclusion Criteria: * Adult patients aged ≥18 years; * Deemed eligible for elective hepatobiliary surgery; * Demonstrated comprehension of the study nature and expressed willingness to comply with trial procedures; * Capable of providing written informed consent. Exclusion Criteria: * History of β-lactam allergy or hypersensitivity * Uncontrolled preoperative infection; * Current or recent (within the preceding month) systemic corticosteroid administration; * Severe hepatic or renal impairment; * Pregnancy or lactation; * Concurrent enrolment in another clinical trial; * Any other condition deemed by the investigator to render the patient unsuitable for study participation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07620223 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hepatobiliary Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07620223 currently recruiting?
Yes, NCT07620223 is actively recruiting participants. Contact the research team at cdy_pharmacy@njglyy.com for enrollment information.
Where is the NCT07620223 trial being conducted?
This trial is being conducted at Nanjing, China.
Who is sponsoring the NCT07620223 clinical trial?
NCT07620223 is sponsored by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School. The trial plans to enroll 378 participants.